Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06481943 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Prospective Research Investigation of Ischemia Using MCG

Study acronym: PRISM/PRISM2
StatusRecruiting
PhaseNot specified
Started2024-07-11
View on ClinicalTrials.gov ↗
PRISM is a prospective, pilot research study that aims to systematically characterize the usefulness of CardiAQ MCG, a bedside magnetocardiography device, in the evaluation of myocardial ischemia and infarction status.

Amendment history 3 changes detected by DataLookout

2026-09-05
notable
Enrollment increased: 150 → 335 participants
2026-09-05
critical
Primary completion pushed: 2026-03 → 2026-12
2026-09-05
minor
Completion pushed: 2026-04 → 2027-02
Trial Details
NCT Number NCT06481943
Lead Sponsor SB Technology, Inc.
Collaborators: Mayo Clinic, Icahn School of Medicine at Mount Sinai
Conditions Acute Coronary Syndrome
Enrollment 335 participants
Start Date 2024-07-11
Primary Completion 2026-12 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2026-09-04